LeadIQ logo
Learn more at LeadIQ.com

Insights

Precision Diagnostics OncoHost is a precision diagnostics company focusing on predictive biomarker development for improved patient care, presenting an opportunity to collaborate with healthcare providers to enhance cancer treatment outcomes.

Global Expansion OncoHost has expanded its reach with the launch of its PROphet® NSCLC Cancer Test in the United States, indicating a potential sales opportunity to explore partnerships and distribution channels in the U.S. market for precision medicine solutions.

Award Recognition OncoHost has been recognized in the healthcare category at the 2023 BIG Innovation Awards, showcasing industry credibility that can be leveraged to build trust with potential clients seeking innovative precision oncology solutions.

Expert Team Addition OncoHost has strengthened its leadership team by hiring seasoned healthcare executives to drive commercial strategies, offering a sales opportunity to engage with key decision-makers and expand business relationships.

Research Collaboration OncoHost's collaboration with Dana-Farber Cancer Institute to identify biomarkers for renal cell carcinoma opens doors for potential collaborative research projects and sales opportunities in the field of personalized cancer therapy.

Similar companies to OncoHost

OncoHost Tech Stack

OncoHost uses 8 technology products and services including WordPress, Cloudflare, Salesforce, and more. Explore OncoHost's tech stack below.

  • WordPress
    Content Management System
  • Cloudflare
    Content Management System
  • Salesforce
    Customer Relationship Management
  • MySQL
    Database
  • Shopify
    E-commerce
  • Microsoft
    Miscellaneous
  • Lua
    Programming Languages
  • Yoast SEO
    Search Engines

Media & News

OncoHost's Email Address Formats

OncoHost uses at least 1 format(s):
OncoHost Email FormatsExamplePercentage
First@oncohost.comJohn@oncohost.com
43%
FirstL@oncohost.comJohnD@oncohost.com
13%
First.Last@oncohost.comJohn.Doe@oncohost.com
1%
First@oncohost.comJohn@oncohost.com
43%

Frequently Asked Questions

Where is OncoHost's headquarters located?

Minus sign iconPlus sign icon
OncoHost's main headquarters is located at Hamelacha Street 17 Floor 1 Binyamina, Israel 3057324 IL. The company has employees across 2 continents, including AsiaNorth America.

What is OncoHost's official website and social media links?

Minus sign iconPlus sign icon
OncoHost's official website is oncohost.com and has social profiles on LinkedIn.

How much revenue does OncoHost generate?

Minus sign iconPlus sign icon
As of September 2024, OncoHost's annual revenue reached $3.8M.

What is OncoHost's NAICS code?

Minus sign iconPlus sign icon
OncoHost's NAICS code is 62 - Health Care and Social Assistance.

How many employees does OncoHost have currently?

Minus sign iconPlus sign icon
As of September 2024, OncoHost has approximately 51 employees across 2 continents, including AsiaNorth America. Key team members include Chief Financial Officer: M. H.Chief Medical Officer: A. D.Chief Commercial Officer (cco): C. D.. Explore OncoHost's employee directory with LeadIQ.

What industry does OncoHost belong to?

Minus sign iconPlus sign icon
OncoHost operates in the Hospitals and Health Care industry.

What technology does OncoHost use?

Minus sign iconPlus sign icon
OncoHost's tech stack includes WordPressCloudflareSalesforceMySQLShopifyMicrosoftLuaYoast SEO.

What is OncoHost's email format?

Minus sign iconPlus sign icon
OncoHost's email format typically follows the pattern of . Find more OncoHost email formats with LeadIQ.

How much funding has OncoHost raised to date?

Minus sign iconPlus sign icon
As of September 2024, OncoHost has raised $35M in funding. The last funding round occurred on May 10, 2022 for $35M.

When was OncoHost founded?

Minus sign iconPlus sign icon
OncoHost was founded in 2017.
OncoHost

OncoHost

Hospitals and Health CareIsrael, Israel51-200 Employees

OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. 

OncoHost’s proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphet® NSCLC test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival. 

Led by an experienced team of entrepreneurs and industry experts and supported by a large-scale prospective clinical trial with over 40 sites and 1,700 patients recruited worldwide, OncoHost is well-positioned to lead precision diagnostics and biomarker development to the next stage.

Section iconCompany Overview

Headquarters
Hamelacha Street 17 Floor 1 Binyamina, Israel 3057324 IL
NAICS Code
62 - Health Care and Social Assistance
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $35M

    OncoHost has raised a total of $35M of funding over 4 rounds. Their latest funding round was raised on May 10, 2022 in the amount of $35M.

  • $10M

    OncoHost's revenue is in the range of $10M

Section iconFunding & Financials

  • $35M

    OncoHost has raised a total of $35M of funding over 4 rounds. Their latest funding round was raised on May 10, 2022 in the amount of $35M.

  • $10M

    OncoHost's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.